Association between infectious event and de novo malignancy after heart transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Heart and Vessels"
DOI: 10.1007/s00380-020-01715-9
Abstract: The aim of the study was to investigate the incidence of and risk factors for de novo malignancy after heart transplantation (HTx) in a single center. We assessed 102 consecutive patients who received HTx and… read more here.
Keywords: malignancy; malignancy heart; novo malignancy; infectious event ... See more keywords
De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2018.03.059
Abstract: OBJECTIVE In patients with living donor liver transplantation (LDLT), late-onset complications sometimes develop because of long-term use of immunosuppressive drugs. One of the immunosuppressive drug-related complications is de novo malignancies resulting in reduced survival. PATIENTS… read more here.
Keywords: adult; novo malignancy; transplantation; cancer ... See more keywords
Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14714
Abstract: Nonalcoholic steatohepatitis (NASH) is associated with metabolic conditions that increase the risk of de novo malignancy following transplant. Patients often have more than one underlying liver disease, which could change the risk of de novo… read more here.
Keywords: liver; malignancy; risk novo; novo malignancy ... See more keywords